Lung carcinoma patients aged eighty years over and prognostic factors affecting survival

dc.authoridAkbay, Makbule Özlem/0000-0002-2459-8022
dc.authoridYalçınsoy, Murat/0000-0003-3407-7359
dc.authoridGungor, Sinem/0000-0002-1163-125X
dc.authoridArınç, Sibel/0000-0002-2443-2639
dc.authoridKasapoglu, Umut Sabri/0000-0003-2869-9872
dc.authorwosidAkbay, Makbule Özlem/JAD-1574-2023
dc.authorwosidYalçınsoy, Murat/ABI-1421-2020
dc.authorwosidGungor, Sinem/GPX-1807-2022
dc.authorwosidGungor, Sinem/AAZ-7783-2021
dc.authorwosidArınç, Sibel/ADP-9208-2022
dc.authorwosidKasapoglu, Umut Sabri/F-1786-2019
dc.contributor.authorKasapoglu, Umut Sabri
dc.contributor.authorGungor, Sinem
dc.contributor.authorArinc, Sibel
dc.contributor.authorYalcinsoy, Murat
dc.contributor.authorMisirlioglu, Aysun
dc.contributor.authorAkbay, Ozlem Makbule
dc.date.accessioned2024-08-04T20:44:00Z
dc.date.available2024-08-04T20:44:00Z
dc.date.issued2017
dc.departmentİnönü Üniversitesien_US
dc.description.abstractIntroduction: Almost 50% of all cancers and 70% of cancer deaths occur in cases aged 65 years and more. Thus diagnosis, treatment and follow up in old cases gain importance. Since there a limited number of study that show age-mortality relation in lung cancer cases aged 80 years and over, issues may arise in diagnosis and treatment process of these cases. In this study, we aimed to evaluate general characteristics of lung cancer cases aged 80 years or over and factors that affect survey. Materials and Methods: Between 2010 and 2013, the retrospective cohort study was done in Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital and 100 cases of lung carcinoma were examined. Results: In the study, 70% of the cases were male and 30% were female. Median age was 83 +/- 2.91 (80-92) years. 71% of the cases were found to be suffering from a comorbid disease; 29% did not have any comorbid disease. Dyspnea (56%), cough (50%) and chest pain (41%) were the most frequent symptoms. Histopathologically, 41% of the patients diagnosed with adenocarcinoma and 40% were diagnosed with squamous cell carcinoma. Median survival time was 2.73 months (% 95 CI 0.96-4.49) and 1-year survival rate was 17%. Length of time of the cases with smoking history was found shorter than of cases without smoking history (p=0.013). Life expectancy of the cases with advanced disease and performance score of 3-4 was detected to be short (p=0.006, p< 0.001). Compared to the cases who operated on and had chemoradiotherapy, length of life who had symptomatic treatment was shorter (p< 0.001). Conclusion: Despite the comorbidity in lung cancer cases aged 80 years and over, life expectancy of the cases who had surgical and/or chemoradiotherapy treatment is longer. While deciding on treatment methods on these cases, patient's performance must be taken into consideration.en_US
dc.identifier.doi10.5578/tt.27881
dc.identifier.endpage105en_US
dc.identifier.issn0494-1373
dc.identifier.issue2en_US
dc.identifier.pmid28990888en_US
dc.identifier.scopus2-s2.0-85029698680en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage97en_US
dc.identifier.urihttps://doi.org/10.5578/tt.27881
dc.identifier.urihttps://hdl.handle.net/11616/97976
dc.identifier.volume65en_US
dc.identifier.wosWOS:000419204600004en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isotren_US
dc.publisherTurkish Assoc Tuberculosis & Thoraxen_US
dc.relation.ispartofTuberkuloz Ve Torak-Tuberculosis and Thoraxen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectLung canceren_US
dc.subjectelderlyen_US
dc.subjectprognosisen_US
dc.subjectsurvivalen_US
dc.subjectchemotheraphyen_US
dc.titleLung carcinoma patients aged eighty years over and prognostic factors affecting survivalen_US
dc.typeArticleen_US

Dosyalar